Under the first sale doctrine, once a trademark owner first authorizes its branded product to be sold to a consumer, the trademark owner’s right to control the further re-sale of that product is generally said to be...more
3/1/2019
/ Attorney's Fees ,
Consumer Confusion ,
Corporate Branding ,
Cosmetics ,
Damages ,
False Advertising ,
False Designation of Origin ,
Fashion Industry ,
FDA Approval ,
First Sale Doctrine ,
Gray Market Goods ,
Imports ,
Injunctive Relief ,
Lanham Act ,
Materiality ,
Product Packaging ,
Quality Control Plan ,
Tariff Act of 1930 ,
Tortious Interference ,
Trademark Exhaustion ,
Trademarks ,
U.S. Customs ,
Unfair Competition
More than two and a half years after the China Food and Drug Administration (CFDA) formally approved its first three-dimensional (3D) printed medical device for mass production, a hip implant co-developed by Peking...more
The U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb recently announced that the agency plans to publish a draft guidance outlining a voluntary alternative pathway for new, moderate-risk devices for use in...more